The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 342:422-424 February 10, 2000 Number 6
NextNext

Sudden Death in Hypertrophic Cardiomyopathy

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Maron, B. J.
-PubMed Citation
Few problems are harder for physicians and patients alike than having the ability to predict, but not to avert, adverse events; few adverse events are harder to deal with than sudden death in young people. Thus, familial hypertrophic cardiomyopathy presents an extreme problem in medical management. Recent insights into the genetic basis of hypertrophic cardiomyopathy have not yet led to new, rationally designed treatments, so our diagnostic capabilities have outpaced the therapeutic options. The article by Maron and colleagues1 in this issue of the Journal shows the value of an empirical approach to the prevention of sudden death in patients . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.